Physician profile
Taylor M Young
NPI 1538982244
$550.30
in general payments reported to CMS, 2019-2025
9 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $152 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $122.69 | 2024 | Valtoco |
| Ucb, INC. | $121.67 | 2025 | Zilbrysq, Fintepla |
| Grifols USA, LLC | $88.06 | 2025 | Gamunex-C |
| Teva Pharmaceuticals USA, INC. | $61.57 | 2025 | Austedo Xr |
| Sk Life Science, INC. | $39.89 | 2025 | |
| Argenx US, INC. | $34.74 | 2025 | Vyvgart Hytrulo |
| Amgen INC. | $34.29 | 2025 | Uplizna |
| Alexion Pharmaceuticals, INC. | $29.18 | 2024 | Ultomiris |
| Takeda Pharmaceuticals U.S.A., INC. | $18.21 | 2025 | Hyqvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.